Join to View Full Profile
160 East 53rd StreetNew York, NY 10022
Dr. Alonso Martinez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Salvador Alonso Martinez is a Houston-based oncologist who specializes in several conditions, including colon and rectal cancer. Martinez concluded his education with a Fellowship in Medical Oncology from the Memorial Sloan Kettering Cancer Center in 2022 after his Residency in Internal Medicine from the Massachusetts General Hospital in 2019. Additionally, Dr. Martinez has made notable contributions to the medical field through his multiple published works in renowned journals like the Journal of Clinical Investigation. His research has also been cited by other authors.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2016 - 2019
Escuela de Medicina Ignacio A. SantosClass of 2014
Certifications & Licensure
FL State Medical License 2023 - Present
AZ State Medical License 2025 - 2027
GA State Medical License 2025 - 2027
LA State Medical License 2025 - 2027
OK State Medical License 2025 - 2027
TN State Medical License 2025 - 2027
TX State Medical License 2024 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsComprehensive microRNA analysis across genome-edited colorectal cancer organoid models reveals miR-24 as a candidate regulator of cell survival.Jonathan W Villanueva, Lawrence Kwong, Teng Han, Salvador Alonso Martinez, Michael T Shanahan
BMC Genomics. 2022-12-01 - 3 citationsSimplified Graded Infusion Strategy for Mitigation of Oxaliplatin Hypersensitivity.Salvador Alonso Martinez, Neil H Segal, Andrea Cercek, Rona Yaeger, Zsofia Stadler
Clinical Colorectal Cancer. 2022-06-01
Press Mentions
Study Uncovers Mechanisms Behind KRAS Inhibitor Resistance in Colorectal CancerMay 23rd, 2026- New Discovery Maps How Mutant Colorectal Tumors Adapt to KRAS InhibitorsMay 28th, 2026
Grant Support
- Targeting regenerative reprogramming in colorectal cancerUNIVERSITY OF TX MD ANDERSON CAN CTR2024–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
